Metacrine

Metacrine is a clinical-stage biopharmaceutical company dedicated to establishing innovative, first-class drug therapies for the treatment of liver and gastrointestinal (GI) diseases. The most advanced programs focus on Farnesoid X Receptor (FXR), a key drug target for various liver and GI diseases. In addition to the FXR program, Metacrine is also leveraging its internal drug discovery and development capabilities to explore novel candidates targeting other drug targets.